Analysis, reports, chat and Advanced access use the same ShareKeyX account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Reported and computed values remain separate; missing values are not converted to zero.
Research path: Interpret Max Healthcare Institute's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
Calculated from validated daily candles. Descriptive research only.
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
IND AS · INR crore
| Metric | 2026 | 2025 | 2024 |
|---|---|---|---|
| Total Liabilities Shareholders' Equity | 17,230.94 | 15,214.48 | 11,999.94 |
| Accumulated Depreciation Total | -1,795.27 | -1,556.41 | -947.87 |
| Cash Equivalents | 574.07 | 561.25 | 933.05 |
| Other Liabilities Total | 631.86 | 604.04 | 639.77 |
| Accrued Expenses | 54.31 | Not available | Not available |
| Long Term Debt | 2,437.55 | 2,268.51 | 1,058.26 |
| Common Stock Total | 973.13 | 972.14 | 971.91 |
| Other Equity Total | -7.63 | -6.05 | -1.5 |
| Other Current Assets Total | 37.43 | 20.42 | 119.43 |
| Prepaid Expenses | 32.73 | 28.51 | 13.11 |
| Total Assets | 17,230.94 | 15,214.48 | 11,999.94 |
| Current Portof LT Debt/Capital Leases | 408.34 | 179.09 | 49.19 |
| Additional Paid-In Capital | 5,238.2 | 5,184.15 | 5,181.75 |
| Cash | 91.73 | 100.33 | 46.79 |
| Total Equity | 10,746.63 | 9,380.87 | 8,408.14 |
| Long Term Investments | 10.12 | 7.55 | 65.15 |
| Retained Earnings(Accumulated Deficit) | 4,542.93 | 3,230.63 | 2,255.98 |
| Total Common Shares Outstanding | 97.31 | 97.21 | 97.19 |
| Property/Plant/Equipment Total-Gross | 9,367.47 | 7,918.79 | 4,638.95 |
| Tangible Book Valueper Share Common Eq | 48.7 | 34.41 | 29.07 |
| Goodwill Net | 3,488.24 | 3,480.26 | 2,952.47 |
| Total Liabilities | 6,484.31 | 5,833.61 | 3,591.8 |
| Total Debt | 3,478.36 | 3,010.29 | 1,298.95 |
| Cashand Short Term Investments | 665.8 | 661.58 | 979.84 |
| Total Receivables Net | 1,094.55 | 775.85 | 513.96 |
| Notes Payable/Short Term Debt | 92.04 | 63.59 | 61.29 |
| Deferred Income Tax | 687.53 | 648.19 | 514.85 |
| Accounts Receivable-Trade Net | 1,031.8 | 735.9 | 498.81 |
| Property/Plant/Equipment Total-Net | 7,572.2 | 6,362.38 | 3,691.08 |
| Total Current Liabilities | 2,186.94 | 1,813.77 | 1,248.71 |
| Total Inventory | 114.28 | 106.21 | 79.84 |
| Accounts Payable | 859.04 | 807.92 | 677.47 |
| Other Currentliabilities Total | 773.21 | 763.17 | 460.76 |
| Total Long Term Debt | 2,977.98 | 2,767.61 | 1,188.47 |
| Intangibles Net | 2,519.01 | 2,555.01 | 2,630.15 |
| Other Long Term Assets Total | 419.37 | 380.64 | 362.53 |
| Note Receivable-Long Term | 1,277.21 | 836.07 | 592.38 |
| Total Current Assets | 1,944.79 | 1,592.57 | 1,706.18 |
| Capital Lease Obligations | 540.43 | 499.1 | 130.21 |
PEG Ratio7.82
Price to Sale Ratio12.50
Debt 5Yr CAGR %25.86
Operating Margin 12m20.88
Operating Margin 5y Avg21.25
Net Profit Margin 12m17.23
Net Profit Margin 5y18.03
Dividend Yield %0.19
Overall RiskBalanced risk
Board Risk26.55
ConsensusBuy
Consensus score2.20
Analyst opinions25
Strong Sell count0
Sell count4
Hold count3
Buy count12
Strong Buy count6
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Only peers present in the company profile payload are displayed.
| Company | Price | Market cap | P/E | Research |
|---|---|---|---|---|
| Apollo Hospitals Enterprise | INR 8,812.9 | 1.27 L | 64.93 | — |
| Fortis Healthcare | INR 935 | 70,588.59 | 67.89 | — |
| Aster DM Healthcare | INR 844.4 | 44,157.18 | 102.55 | — |
| Narayana Hrudayalaya | INR 1,881 | 38,187.34 | 48.07 | — |
| Global Health | INR 1,440.1 | 38,871.79 | 63.65 | — |
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Max Healthcare Institute Ltd Sees Mixed Technical Signals Amid Mild Momentum Shift Markets Mojo
Max Healthcare Institute Ltd is Rated Sell Markets Mojo
Dinesh Kumar Duua Starts New Role as Vice President at Max Healthcare hrtoday.in
Stock Radar: After a 24% correction, Max Healthcare breaks key resistance level; analysts see long-term po The Economic Times
Max Healthcare Institute Ltd is Rated Sell Markets Mojo
Max Healthcare FY26 PAT rises 22% to INR 1,631 crore scanx.trade
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and ShareKeyX AI.
Max Healthcare Institute Limited is an India-based integrated healthcare provider. The Company offers an integrated suite of diagnostics and lab services, ambulatory care, consultations, surgical and non-surgical procedures, and medical treatment. Its clinical offerings span a range of therapeutic areas, including radiation therapy for cancer, and specialized treatments in oncology, neurosciences, cardiac sciences, orthopedics, renal and liver care and minimally invasive surgery. It also provides consultations across diverse medical specialties such as diabetes and endocrinology, pulmonology, nephrology, dermatology, gastroenterology, physiotherapy and rehabilitation. It also caters to specific healthcare needs, including transplant services, audiology and speech therapy, and dedicated pediatric care. It offers a home care program through Max@Home, enabling patients to receive medical attention in the comfort of their homes. Its Max Lab provides at-home diagnostic testing.
Max Healthcare Institute has the symbol MAXHEALTH and ISIN - INE027H01010.
Max Healthcare Institute is currently trading at INR 997.90.
Max Healthcare Institute has a year high of INR 1,301.70 and a year low of INR 903.00.
Max Healthcare Institute has a market capitalization of INR 1.05 lakh crore.
Max Healthcare Institute has a P/E ratio of 64.80.
Max Healthcare Institute has a dividend yield of 0.19%.
Max Healthcare Institute has revenue of INR 8,373.45 crore, net income of INR 1,442.41 crore, and EPS of INR 15.24.
Max Healthcare Institute has a book value of INR 48.70.
Max Healthcare Institute has a debt-to-equity ratio of NA.
Max Healthcare Institute has a price-to-book ratio of 20.49 and a price-to-sales ratio of 12.50.
Corporate-action adjustment is provider-defined. ShareKeyX research and computed indicators are not investment advice.